Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1629428 | 1.00 | LMNA (0.46) | LMNACYP3A4ALOX15PTPN1GLA | |
| SCHEMBL29454348 | 1.00 | LMNA (0.46) | LMNACYP3A4ALOX15PTPN1GLA | |
| SCHEMBL22293372 | 0.87 | LMNA (0.47) | LMNACYP3A4ALOX15TDP1KMT2A | |
| SCHEMBL22373120 | 0.80 | NR1H4 (0.43) | LMNAGLATDP1KMT2AMEN1 | |
| SCHEMBL5604543 | 0.80 | CES2 (0.51) | LMNACYP3A4ALOX15PTPN1TDP1 | |
| SCHEMBL15470541 | 0.79 | LMNA (0.51) | LMNACYP3A4ALOX15PTPN1KMT2A | |
| SCHEMBL25380943 | 0.79 | LMNA (0.57) | LMNACYP3A4ALOX15PTPN1TDP1 | |
| SCHEMBL25380939 | 0.77 | LMNA (0.59) | LMNACYP3A4ALOX15PTPN1TDP1 | |
| Acetic Acid SCHEMBL1234733 | 0.76 | LMNA (0.57) | LMNACYP3A4ALOX15PTPN1TDP1 | |
| SCHEMBL19919389 | 0.76 | LMNA (0.54) | LMNACYP3A4ALOX15PTPN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3416729-B1 | PRO-FRAGRANCE COMPOSITION | AQDOT LTD (GB) | 2023-09-20 | — | — | EP | disclosed |
| US-20220291237-A1 | Gene Expression Inflammatory Age and Its Uses | Edifice Health, Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| CN-110891615-B | System and method for selecting and releasing fragrance | 阿甘香气及精细化学有限公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-108601958-B | Pro-fragrance compositions | 爱客多有限公司 | 2022-06-17 | — | — | CN | disclosed |
| US-10695277-B2 | Pro-fragrance composition | AQDOT LIMITED (GB) | 2020-06-30 | — | — | US | disclosed |
| US-20190046426-A1 | PRO-FRAGRANCE COMPOSITION | AQDOT LIMITED (GB) | 2019-02-14 | — | — | US | disclosed |
| EP-3416729-A1 | PRO-FRAGRANCE COMPOSITION | Aqdot Limited (GB) | 2018-12-26 | — | — | EP | disclosed |
| WO-2017141030-A1 | PRO-FRAGRANCE COMPOSITION | AQDOT LIMITED (GB) | 2017-08-24 | — | — | WO | disclosed |
| CN-106999972-A | System and method for discharging fragrance | 阿甘芳香和精细化工有限公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106999973-A | System and method for discharging edible material | 阿甘芳香和精细化工有限公司 | 2017-08-01 | — | — | CN | disclosed |
| US-20110093246-A1 | Modeling Systems for Consumer Goods | STANTON DAVID THOMAS | 2011-04-21 | — | — | US | disclosed |
| US-20100248390-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS | DUKE UNIVERSITY (US) | 2010-09-30 | — | — | US | disclosed |
| US-20080040082-A1 | Modeling systems for consumer goods | THE PROCTER & GAMBLE COMPANY | 2008-02-14 | — | — | US | disclosed |
| US-20080027575-A1 | Modeling systems for health and beauty consumer goods | PROCTER & GAMBLE COMPANY, THE | 2008-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190046426-A1 | PRO-FRAGRANCE COMPOSITION | COPS5, COPS8, CBR3 | LMNA 2903/4885CYP3A4 2207/4885ALOX15 451/4885 |
| US-10695277-B2 | Pro-fragrance composition | COPS5, COPS8, CBR3 | LMNA 2903/4885CYP3A4 2207/4885ALOX15 451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.